{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:52:21Z","timestamp":1791186741835,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.gcb.2010.07.018","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T05:40:18Z","timestamp":1283319618000},"page":"29-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis"],"prefix":"10.1016","volume":"35","author":[{"given":"E.M.M.","family":"Kuiper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Lesterhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Robijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.J.B.","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.H.","family":"Koek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Kerbert-Dreteler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.R.","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gcb.2010.07.018_bib0005","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51(2):237\u201367.","DOI":"10.1016\/j.jhep.2009.04.009"},{"issue":"1","key":"10.1016\/j.gcb.2010.07.018_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.gcb.2010.07.018_bib0015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0168-8278(94)80111-8","article-title":"Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis","volume":"21","author":"Leuschner","year":"1994","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.gcb.2010.07.018_bib0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0168-8278(99)80222-0","article-title":"Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis","volume":"31","author":"Van Hoogstraten","year":"1999","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gcb.2010.07.018_bib0025","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gcb.2010.07.018_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.gcb.2010.07.018_bib0035","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gcb.2010.07.018_bib0040","first-page":"178","article-title":"Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria","volume":"30","author":"Taal","year":"1983","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.gcb.2010.07.018_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"10","key":"10.1016\/j.gcb.2010.07.018_bib0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2036.1998.00395.x","article-title":"A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10mg\/kg or 20mg\/kg","volume":"12","author":"Van Hoogstraten","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"22","key":"10.1016\/j.gcb.2010.07.018_bib0055","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gcb.2010.07.018_bib0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/gut.47.4.595a","article-title":"UDCA, PBC, and biochemistry, what does normal mean?","volume":"47","author":"Leuschner","year":"2000","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.gcb.2010.07.018_bib0065","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1478-3231.2006.01304.x","article-title":"The AST\/ALT ratio as an indicator of cirrhosis in patients with PBC","volume":"26","author":"Nyblom","year":"2006","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.gcb.2010.07.018_bib0070","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","article-title":"Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients","volume":"101","author":"ter Borg","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gcb.2010.07.018_bib0075","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gcb.2010.07.018_bib0080","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/j.1572-0241.2001.05268.x","article-title":"Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection","volume":"96","author":"Pohl","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gcb.2010.07.018_bib0085","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gcb.2010.07.018_bib0090","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1872-034X.2008.00474.x","article-title":"Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis","volume":"39","author":"Kikuchi","year":"2009","journal-title":"Hepatol Res"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832010002939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832010002939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:36:31Z","timestamp":1760074591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399832010002939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0399832010002939"],"URL":"https:\/\/doi.org\/10.1016\/j.gcb.2010.07.018","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2010.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}